ARTBIO
Tanja Aarvak is a highly experienced professional in the field of biotechnology and cell therapy. With a PhD in Immunology from the University of Oslo and an MSc in Biotechnology from the Norwegian University of Science and Technology, Tanja has held various senior roles in reputable companies such as ARTBIO, Nordic Nanovector ASA, Thermo Fisher Scientific, and Life Technologies. With a background in product design, program management, and R&D, Tanja's expertise lies in radioligand therapy and cellular medicine. Prior to these roles, Tanja has also worked as a Principal Scientist and Senior Scientist in companies like Invitrogen and Dynal Biotech.
This person is not in any offices
ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.